XOLAIR® (omalizumab)
XOLAIR. Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic...
Read Xolair.com news digest here: view the latest XOLAIR articles and content updates right away or get to their most visited pages. Xolair.com belongs to a large group of moderately popular websites, with around 45K visitors from all over the world monthly. It seems that XOLAIR content is notably popular in USA, as 92.5% of all users (41K visits per month) come from this country. We haven’t detected security issues or inappropriate content on Xolair.com and thus you can safely use it. Xolair.com is hosted with Amazon.com, Inc. (United States) and its basic language is English.
Content verdict: Safe
Website availability: Live
Language: English
Last check:
-
1 482
Visitors daily -
1 482
Pageviews daily -
4
Google PR -
806 746
Alexa rank
Best pages on Xolair.com
-
Learn about XOLAIR®, a self-administered treatment for allergic asthma, chronic rhinosinusitis with nasal polyps, and chronic spontaneous urticaria. See full prescribing, safety, & Boxed Warning info...
-
Allergic Asthma Treatment | XOLAIR® (omalizumab) | HCP
Learn more about Allergic Asthma and discover available treatment options for your patients. See full prescribing and safety info, including Boxed Warning.
-
XOLAIR®(Omalizumab) for HCPs: XOLAIR® Co-Pay Card Program
WARNING: Anaphylaxis Anaphylaxis presenting as bronchospasm, hypotension, syncope, urticaria, and/or angioedema of the throat or tongue, has been reported to occur after admin...
Domain history
| Web host: | Amazon.com, Inc. |
| Registrar: | MarkMonitor Inc. |
| Registrant: | Domain Admin (Novartis AG) |
| Updated: | May 11, 2024 |
| Expires: | December 08, 2025 |
| Created: | December 08, 1999 |
Whois record
Visitor gender
Male
Female
Safety scores
Trustworthiness
GoodChild safety
N/A
